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Lipid raftCurcumin is an important nutraceutical widely used in disease treatment and prevention. We have previously
suggested that curcumin interferes with K+ binding to pig kidney Na,K-ATPase by interaction with its
extracellular domains. The aim of this study was to further characterize the site of curcumin interaction with
the ATPase. We have performed pair inhibitor studies and investigated the sided action of curcumin on pig
kidney Na,K-ATPase reconstituted into lipid vesicles of deﬁned composition. An addition of curcumin to either
the intracellular or extracellular domains of the Na,K-ATPase produced similar inhibition. The lipid
environment and temperature strongly inﬂuenced the potency of the drug. Curcumin inhibition decreased
following insertion of the ATPase in sphingomyelin-cholesterol ‘raft’ domains and fully abolished following
treatment with non-ionic detergents. The drug induced cross-linking of membrane embedded domains of the
Na,K-ATPase. We conclude that curcumin interacts with Na,K-ATPase at the protein-lipid interface. Non-
annulus lipids likely participate in this interaction. These results provide new information on the molecular
mechanism of curcumin action and explain (at least partly) the ambiguous effectiveness of this polyphenol in
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Scientiﬁc interest in ancient medicine has increased strongly
during the last decade, and many efforts have been made to
understand and explain the beneﬁcial effects of many natural herbs.
Curcumin (diferuloylmethane), the active constitute of Curcuma longa
(commonly termed as tumeric), is one of the best studied natural
molecules. Curcumin has been used as a spice [1] and food additive for
centuries, but thereafter the anti-inﬂammatory, antiviral, anti-
infectious and anti-carcinogenic effects of this molecule have become
evident (for recent reviews see Refs. [2,3]). Of particular medical
signiﬁcance is the possible connection of curcumin intake with the
treatment of several physiological disorders [4–7]. It is not until
several years ago that curcumin was found to directly interact with a
variety of enzymes: Curcumin has been shown to modulate the
activity of protein kinases [8–10], mitochondrial F0F1-ATPases [11]
and transcription factors [12]. This broad speciﬁcity suggests that the
drug interacts with a common domain on these targets.Curcumin also modulates the activity of transmembrane P-type
pumps [13–16]. As an inhibitor of sacroplasmic reticulum Ca2+-
ATPase, curcumin was shown to be useful in the treatment of cystic
ﬁbrosis [5], although there have been some inconsistencies on this
matter [5,17–20]. The activity of membrane proteins is modulated by
lipids [21]. Indeed, several signaling cascades involve activation of
membrane receptors that requires sequestration into speciﬁc lipid
domains (rafts, for recent review see Ref. [22]). A typical example is
the synchronization by lipid rafts of NFκB activation by interleukin 1β
[23]. Hence, membrane-dependent events deﬁnitely play a substan-
tial role in membrane protein function and regulation.
Understanding how curcumin interacts at its binding site(s) on
target proteins is an important goal, as it will give information about its
mechanism of action and allow us to understand how this molecule
affect such large number of targets. We have been interested in the fact
that curcumin modulates several proteins that are structurally and
functionally unrelated but share the common property of being
membrane-bound proteins, downstream proteins of membrane recep-
tor-activated signaling cascades, or proteins that associate with cellular
membranes upon activation (such as protein kinase C). This raises the
possibility that curcumin interaction with its target proteins may be
regulated by the lipid environment. Here, we address this issue by
studying the sided action of curcumin on Na,K-ATPase reconstituted
into lipid vesicles of deﬁned lipid composition. We have found that the
inhibitory effect of curcumin, including its strong effect on K+ afﬁnity,
was independent of whether curcumin binds to the Na,K-ATPase from
the extracellular- or the cytoplasmic-side, suggesting that this molecule
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structure was found to be an important determinant of curcumin
potency. The interaction of curcumin with transmembrane domains of
membrane proteins in a lipid dependent manner seems to be a general
mechanism that needs auxiliary attention to understand the pharma-
cological properties of this polyphenol.
2. Methods
2.1. Na,K-ATPase preparation and hydrolytic activity
Pig kidneymembrane fragments rich in Na,K-ATPasewas prepared
as previously described [24] but with little modiﬁcations as follows:
the outer renal medulla tissue was homogenized in 30 mM histidine
buffer (pH 7.4 at 20 °C) containing 250 mM sucrose and 1 mM EDTA
(HSE buffer). The microsomal fraction was opened and peripheral
contaminating proteins removed by incubation with a low concen-
tration of SDS (estimated from calibration curves in which increasing
SDS concentrations were employed) and the washed protein was
ﬁnally suspended in HSE buffer. Themaximumhydrolytic activity was
around 1400 μmol−1h−1mg−1 at 37 °C. The activity was determined
by measuring ouabain-dependent ATP hydrolysis after incubation of
the enzyme with substrate ions, MgATP, and inhibitors in the
presence of either DMSO (dimethyl sulfoxide) vehicle or curcumin
(details are in separate ﬁgure legends). In the case of measuring
ATPase activity in the presence of the non-ionic detergent C12E10, the
ATPase assay was performed exactly as above but in the presence of
increasing detergent concentrations.
2.2. Reconstitution of Na,K-ATPase
Pig kidney Na, K-ATPase was reconstituted into lipid vesicles of
dipalmitoyl phosphatidylcholine (PC) containing 30 mol% cholesterol
(Chol), as described previously [25]. In some experiments, 5 mol%
phosphatidyl serine (PS) was included. In this artiﬁcial system active
Na,K-ATPase molecules are oriented either inside-out (the cytoplas-
mic domains are facing the extra-liposomal medium), right-side out
(the cytoplasmic domains are oriented inside the liposomal lumen),
or non-oriented (enzyme molecules are randomly adsorbed on
liposome surface). The reconstitution buffer contained 20 mM
histidine, pH 7.05, 2 mM MgCl2, and 260 mM sucrose. Reconstitution
was performed in the absence or in the presence of 25 μM curcumin.
Extra-vesicular curcumin was in some cases removed from the
external medium by passing the liposome suspension through
Benefsky columns [26] just before use in hydrolytic assays. Controls
were prepared in exactly the same way, except that curcumin was
replaced by the same volume of DMSO. Prior to the ATPase test,
liposomes was preincubated in a buffer containing 1 mM Na2HPO4
and 1 mM ouabain to inhibit the non-oriented Na,K-ATPase with no
effect on inside-out pumps [27]. Potassium activation of ATP
hydrolysis by inside-out Na,K-ATPase in liposomes was measured in
the presence of 100 mM NaCl, 2 mM MgCl2 (ﬁnal concentration),
1 mM ouabain, 20 μM ATP (containing 104 cpm 32P-[ATP]) and
different concentrations of potassium chloride. Several experiments
were performed to conﬁrm that curcumin does not increase the
permeability of the membrane to ions or ATP, thereby activating the
right-side out oriented pumps (see later discussion). In order to
prepare liposomes containing raft domains, reconstitution was
performed by mixing PC, Chol, sphingomyelin (SM), brain cerebro-
sides (CB) at a mole ratio of 50/30/10/10 mol%, respectively,
essentially as previously described [28].
2.3. Proteolytic cleavage
Extensive proteolytic cleavage of membrane-bound Na,K-ATPase
was performed using trypsin and ended up with the “19 kDamembranes”, i.e., membranes with Na,K-ATPase lacking all cytoplas-
mic domains and containing intact transmembrane domain fragments
connected with hairpin loops [29,30]. One mg of puriﬁed protein was
incubated with 0.2 mg trypsin at either 24 °C (liposomes) or 37 °C
(native membranes) for 1 h, in the presence of 20 mM histidine, pH
7.0, 5 mM EDTA and 25 mM KCl. The post-tryptic membranes were
washed at least two times in cold imidazole 25 mM buffer (pH 7.0)
containing 10 mM KCl. Finally, the membranes were washed twice in
histidine buffer, ﬁnally homogenized in 20 mM histidine containing
25% glycerol, and immediately used for cross-linking experiments.
2.4. Effect of curcumin on membrane permeability
We performed a simple experiment to conﬁrm that curcumin does
not increase liposome membrane permeability. First, inside-out- and
non-oriented Na,K-ATPase were proteolytically degraded by incuba-
tion with trypsin at 24 °C for 30 min in the presence of 20 mM
histidine, pH 7.0, 3 mM EDTA and 20 mM K+ [29,30]. This treatment
results in the complete loss of ATPase activity of these two
populations while preserving the integrity of right-side out pumps
because trypsin has no access to the internal lumen of the vesicles.
Only right-side out oriented Na,K-ATPasemolecules remain intact, but
they are not active unless they have access to Na+, K+, and MgATP.
Vesicles containing only functional right-side out pumps were then
incubated with the above mentioned substrates, plus different
curcumin concentrations. Destabilization of the membrane by
curcumin would result in increase in membrane permeability and
activate right-side out pump molecules to hydrolyse ATP. Hence,
ouabain-dependent ATP hydrolysis was monitored at different
periods of time up to 2 h. Positive control experiments were
performed in which C12E10 or alamethicin were used. Curcumin
concentrations up to 200 μM did not lead to increased ATP hydrolysis
by right-side out oriented pumps. On the other hand, addition of
1 μg ml–1 alamethicin (making the vesicles leaky) or 2 mM C12E10
(opening the vesicles) permits access to Na+ and ATP of the
cytoplasmic-side of the enzyme and resulted in a 100-fold increase
in ATP Hydrolysis. It should bementioned that the lack of activation of
right-side out Na,K-ATPase following curcumin treatment is most
likely a consequence of membrane stability and not an inhibition of
Na,K-ATPase by curcumin. This is because is it established that
curcumin even at relatively high concentrations (~200 μM), does not
produce full inhibition of pig kidney Na,K-ATPase (see Fig. 1 in Ref.
[16]). Hence, if curcumin increases membrane permeability for Na,K-
ATPase substrates, even a small increase in ATP hydrolysis must have
been observed, which was not the case.
2.5. Cross-linking
Cross-linking of membrane imbedded transmembrane domains of
the Na,K-ATPase α-subunit in the absence or in the presence of
curcumin was performed by incubating 100 μg protein with either
DMSO or 30 μM curcumin in the presence of 20 mM Hepes-KOH, pH
6.8, 20 mMKCl, and 1 mM EDTA. Cross-linking was also carried out by
incubating the membranes with 50 μM Bis-(sulfosuccinimidyl)sube-
rate (BS3) in the presence of 20 mM HEPES, pH 6.5, and 5 mM EDTA.
The reaction was allowed to proceed for 20 min at 23 °C, and
terminated by addition of SDS sample buffer [31] followed by loading
to SDS gels. BS3 cross links primary amines and it possibly cross links
lysine residues located close to the inner face of the plasmamembrane
in the M5M6 transmembrane domains and in the C-terminal 19 kDa
fragment (unpublished data).
2.6. Gel electrophoresis and immunoblotting
Proteins were separated using Tricine-based SDS-Polyacrylamide Gel
Electrophoresis, as previously described [32,33]. For immunoblotting,
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thenwashed three timeswithphosphate-buffered saline (PBS) containing
5% Tween-20, and incubated over night at room temperature with the
primaryantibody. ThePVDFmembraneswerewashedagainwithPBSand
incubated with goat anti-rabbit antibody for 2 h at room temperature.
After washing, protein fragments were detected using enhanced
chemiluminescence (ECL) reagent. For the detection of the 19 kDa C-
terminal fragment, a speciﬁc C-terminal α-antibody, α 1002–1016, was
used (a generous gift from Dr. J. V. Møller, Department of Physiology and
Biophysics, University of Aarhus).
2.7. Isolation of low density membranes from ‘total’ pig kidney
membranes
Low density membranes were isolated from total plasma mem-
branes by the detergent-free method introduced by Song et al. [34].
Brieﬂy, the membranes were suspended in 20 mM HEPES containing
500 mM sodium carbonate, (adjusted to pH 9 with HCl). The
sonication step employed by Song et al. was replaced with 10
successive up and down homogenization steps using a motor driven
tight Teﬂon homogenizer running at a speed of ~2500 rpm. The
homogenate was loaded onto a continuous sucrose density gradient
(sucrose concentrations from top to bottom ranging between 4% and
40% sucrose, dissolved in 20 mM HEPES pH 7.4, 1 mM EDTA, and
150 mMNaCl) and centrifuged for 12 h at 100,000 g (4 °C) in a swing-
out rotor SW28. Following centrifugation, 2.5 ml aliquots from the top
of the tube were aspirated (total of 10 fractions). Low density
membranes are localized near the top of the tube whereas heavy
membranes were localized near the bottom. Finally, aspirated
samples were diluted in 20 mM imidazole buffer, pH 7.0, and
centrifuged for 50 min at 200,000 g (4 °C). The different fractions
were tested for protein concentration, the presence of ouabain-
dependent Na,K-ATPase activity, and by immunoblotting.
3. Results
3.1. Paired inhibitor studies
Using pairs of pump inhibitors, indirect information about the
binding site of an inhibitor can be obtained, provided that the binding
site of another inhibitor is known. If binding of inhibitor I decreases
binding of inhibitor II in a competitive manner, then the binding sites
of both inhibitors are (either directly or indirectly) related. On theFig. 1. Effect of curcumin on the apparent afﬁnity for other sodium pump inhibitors. In the
oligomycin or ouabain were measured in the presence of curcumin concentrations ranging f
bottom)/(1+10X−Log EC50)]. The different EC50 values for oligomycin (Panel A) or ouabain (p
ATPase assays contained 20 mM histidine buffer, pH 7.0, 130 mM NaCl, 20 mM KCl, 3 mM
ouabain (Panel B) concentrations. The strong increase in the EC50 for oligomycin followin
abrogated by curcumin, and hence the two inhibitors share the same binding site. This is nother hand, if binding of inhibitor I has no effect on the inhibition by
inhibitor II, then the two inhibitors bind at different sites on the
ATPase. Consequently, we have compared the effect of curcumin on
puriﬁed enzyme treated with Na,K-ATPase inhibitors that have been
estimated to bind to known sites on the Na,K-ATPase. Hence,
inhibition curves by oligomycin or ouabain have been measured in
the presence of different curcumin concentrations, and the relation of
the amount of added curcumin to the apparent afﬁnity of oligomycin
or ouabain have been determined. Data have been conveniently
normalized such that 100% activity represents the activity in the
absence of inhibitor. As seen in Fig. 1A, the apparent afﬁnity for
oligomycin decreased strongly in a linear fashion by the addition of
increasing curcumin concentrations (the EC50 for oligomycin in-
creased from 1.5±0.18 μM in the absence of curcumin to 3.9±
0.12 μM in the presence of 40 μM curcumin), demonstrating that
curcumin decreases the inhibitory potency of oligomycin. This is
possibly due to competition for the Na,K-ATPase α-subunit. Using
ouabain instead of oligomycin, we could demonstrate that curcumin
treatment did not signiﬁcantly affect the EC50 of ouabain (Fig. 1B),
indicating that curcumin and ouabain interact at different sites on the
ATPase. Indeed, it has been found that the inhibition by curcumin and
ouabain is additive, this is not the case with oligomycin (data not
shown).
3.2. The sided action of curcumin on reconstituted Na,K-ATPase
Based on studies in which pig renal membrane fragments were
used, we have previously proposed that curcumin binds at the
extracellular domains of the Na,K-ATPase, as evidenced from its
inhibitory effect that was associated with a signiﬁcant decrease in K+
interaction [16]. As a continuation to those studies, we have compared
the effect of curcumin on pig kidney Na,K-ATPase in native
membranes (see Ref. [16]) and Na,K-ATPase reconstituted into tight
vesicles of deﬁned lipid composition (this study). To further
characterize the binding site of curcumin on the Na,K-ATPase, we
investigated the functional effects of curcumin allowed to interact
with the cytoplasmic domains of the Na,K-ATPase. This was achieved
bymeasuring the activity of reconstituted inside-out Na,K-ATPase, the
function of which can be dissected by pre incubation with ouabain in
the presence of magnesium and inorganic phosphate. This incubation
results in full inhibition of non-oriented pumps with no effect on
inside-out pumps (see Ref. [27] for details). If curcumin interacts at
the extracellular domains of the α-subunit, it will not inhibit these experiments puriﬁed membrane-bond Na,K-ATPase was used. Inhibition curves by
rom 0 to 40 μM. Data were analyzed using dose–response function: Y=bottom+[(top-
anel B) were blotted as a function of the curcumin concentration used, as indicated. The
ATP, 3 mM MgCl2, 3 μg pig kidney Na,K-ATPase, and several oligomycin (Panel A) or
g curcumin treatment implies that the interaction of oligomycin with Na,K-ATPase is
ot the case for ouabain. ATPase activity was measured at 24 °C.
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essentially as ouabain, which does not inhibit inside-out Na,K-
ATPase). Results presented in Fig. 2A (squares) demonstrate that
curcumin, added to the extra-vesicular medium, inhibit inside-out Na,
K-ATPase in the same manner as it does with open membrane
fragments [16], albeit the afﬁnity of inhibition was considerably
higher (see later discussion). To test the effect of curcumin interacting
from the extracellular side of the pump, inside-out and non-oriented
pumps were ﬁrst deactivated by treatment with trypsin followed by
washing through Penefsky columns to remove trypsin from the
medium [26], as described in Methods section. Subsequently, the
cytoplasmic domains of right-side out pumps inside the liposomal
lumen were given access to substrates by the addition of 1 μg ml−1
alamethicin. This makes the liposome membrane leaky to medium
components. As seen in Fig. 2A (circles), addition of curcumin to the
medium resulted in inhibition of the right-side out pumps. The
inhibition was identical to that obtained with the inside-out pumps.
To further investigate the sided action of curcumin on Na,K-
ATPase, we have measured the effect of a single curcumin concen-
tration on K+ activation of either inside-out or right-side out pumps.
Curcumin was added to the medium to allow interaction with
cytoplasmic domains of inside-out Na,K-ATPase or added to leaky
vesicles after deactivation of inside-out pumps by proteolytic
degradation to allow for interaction with the extracellular domains
of right-side out pumps, as described above. In this experiment the
effect of curcumin on the afﬁnity of K+, measured as K0.5(K+)/Vmax
was studied [16]. As seen in Fig. 2B, the curcumin induced inhibition
and decrease in the apparent afﬁnity of the pump for K+ were almost
the same in both cases. Interestingly, the effect of curcumin on the
apparent afﬁnity of reconstituted Na,K-ATPase for K+ was found to be
much more signiﬁcant than early observed in the native enzyme.
Thus, in native membrane-bound enzyme, treatment with 25 μM
curcumin increased the K0.5 for K+ by three fold compared to the
control [16]. On the other hand, in the reconstituted system, the K0.5
for K+ increased by almost 10 fold following treatment with the same
concentration of curcumin (the K0.5 for K+was 65.7±4.6 μM, 637.5±
38.3 μM, and 703.0±42.1 μM for the reconstituted control, inside-out
pumps, and right-side out pumps, respectively). It is not likely that the
observed difference in K+ afﬁnity is due to limited K+ equilibrationFig. 2. Effect of curcumin on reconstituted pig kidney Na,K-ATPase. A. The activity of inside
1 mM inorganic phosphate to inhibit the non-oriented pumps. In this particular experiment
prevent reactivation of non-oriented pumps. The activity of right-side out pumps were m
incubation of the liposomes in ATPase assays containing 1 μg.μl−1 alamethicin to make the v
130 mM Na+, 20 mM K+, 2 mM MgCl2, 20 μM ATP, 0.2 μg nigericin (K+ congener), and the
curve gave an EC50 for curcumin inhibition of 10.16±1.15 and 9.5±1.21 for inside-out (□)
ATPase reconstituted into liposomes was measured at 24 °C in the absence of curcumin (□),
presence of 25 μM curcumin loaded into liposomes (⋄). The reaction mixture contained 1
curcumin concentrations. Analysis of the data using a hyperbolic function gave a K0.5 (K+) of 6
the K0.5(K+) in the absence of curcumin is not appreciably changed after reconstitution (seacross the liposomalmembrane, since the addition of nigericin rapidly
compensate for K+ depletion from the vesicle lumen. Rather, the
membrane lipid structure seems to be important for the modulation
of the interaction of curcumin with the enzyme. Finally, we have
performed several control experiments to make sure that curcumin
does not affect membrane permeability (see Methods section).3.3. Curcumin potency depends on speciﬁc lipid molecules in the
membrane and on temperature
To investigate the effect of membrane surface charge on curcumin
interaction, we have studied the effect of co-reconstitution of PS on
curcumin inhibition of Na,K-ATPase. Control liposomes and liposomes
containing 5 mol% PS was incubated with increasing curcumin
concentrations and the EC50 of inhibition was determined by ﬁtting
sigmoid dose–response function to the data. As seen in Fig. 3, in the
presence PS in the bilayer, the EC50 for curcumin inhibition decreased
by almost three fold, which is consistent with an increased afﬁnity for
inhibition. Thus, curcumin inhibited Na,K-ATPase in PC-cholesterol
vesicles with an EC50 of 15.7±0.55 μM. Following insertion of the
ATPase in PC–Chol–PS vesicles, the EC50 decreased to 5.19±0.26 μM.
Rafts are lipid domains enriched in sphingolipid and cholesterol
that have been shown to participate in several cellular functions and
are known to contain several marker proteins important for raft
function [22]. We have been interested in testing how lipid rafts
would affect the potency of curcumin against one of its targets. Hence,
the effect of curcumin on Na,K-ATPase reconstituted in lipids enriched
in cholesterol and sphingolipids was investigated. Previous studies
have documented that rafts isolated from native membranes and that
prepared from the mixing of synthetic raft components have similar
physical behavior [28] and this allowed us to investigate a possible
relation between raft membrane association and curcumin potency.
Na,K-ATPase was reconstituted in PC–Chol alone or in combination
with sphingomyelin and cerebrosides, and curcumin inhibition curves
were measured in both cases. As seen in Fig. 4A, reconstitution of the
ATPase in raft containing membranes strongly decreased the potency
of curcumin. Fitting a sigmoid dose–response function to the data
showed that curcumin inhibited Na,K-ATPase in PC-cholesterol-out pumps (□) was measured at 24 °C following pre incubation in 1 mM ouabain and
the ouabain concentration in the ATPase reaction was kept constant at 1 mM ouabain to
easured by ﬁrst inhibiting inside-out and non-oriented pumps by trypsin followed by
esicles leaky to ions and ATP (Ο). The ATPase assay contained 20 mM histidine, pH 7.0,
indicated curcumin concentrations. Analysis of the data using a sigmoid dose–response
and right-side out (Ο) pumps, respectively. B. The ATPase activity of inside-out Na,K-
in the presence of 25 μM curcumin added in the extra-liposomal medium (Ο), or in the
00 mM Na+, 20 mM K+, 2 mM MgCl2, 20 μM ATP, 0.2 μg nigericin, and the indicated
5.7±4.6 μM(□), 637.5±38.3 μM(Ο), and 703.0±42.1 μM(⋄), respectively. Note that
e Ref. [16]).
Fig. 3. Effect of co-reconstitution of PS on curcumin inhibition of Na,K-ATPase. The activity
of PC–Chol reconstituted inside-out pumps was measured at 24 °C following pre
incubation in 1 mM ouabain and 1 mM inorganic phosphate to inhibit the non-oriented
pumps. In this particular experiment theouabain concentration in theATPase reactionwas
kept constant at 1 mM ouabain to prevent reactivation of non-oriented pumps (□). The
same experiment was performed with the exception that 5 mol% PS was included (Ο) as
described in Methods section. The ATPase reaction contained 20 mM histidine, pH 7.0,
130 mM Na+, 20 mM K+, 2 mM MgCl2, 20 μM ATP (containing 104 cpm AT32P-[ATP] per
reaction), 0.2 μg nigericin, and 25 μM curcumin. Data were analyzed using dose–response
function which gave an EC50 for inhibition of 15.7±0.55 μM and 5.19±0.26 μM for the
PC–Chol mixture and the PC–Chol–PS mixture, respectively.
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ATPase in raft vesicles, the EC50 increased to 25.9±0.52 μM.
We have also attempted to answer the question of whether native
pig renal membranes contain Na,K-ATPase molecules resident in raft-
like domains. Rafts are characterized by their association with low
density fractions in continuous sucrose density gradients following
equilibrium centrifugation [34]. Consequently, we have submitted
native membrane-bound Na,K-ATPase onto a continuous sucroseFig. 4. Effect of cholesterol-sphingolipid on curcumin inhibition of Na,K-ATPase. A. The activity
1 mM inorganic phosphate to inhibit the non-oriented pumps. In this particular experiment
prevent reactivation of non-orientedpumps (□). The same experimentwasperformedwith the
membranes, Ο) as described in Methods section. The ATPase reaction contained 20 mM histidi
[ATP] per reaction), 0.2 μg nigericin, and 25 μM curcumin. Datawere analyzed using dose–respo
PC–Chol mixture and the PC–Chol–SM–SB mixture, respectively. B. Upper panel. Western blo
(fractions 1–3). Heavy membranes are associated with fractions 6–9. Lower panel. Shown is
indicated. The ATPase mixture was identical to that in panel A, except that nigericin was omitt
using dose–response function which gave an EC50 for inhibition of 8.1±0.46 μM and 15.8±0
membranes fractions 2 (LowDensityMembranes,□) and 8 (HighDensityMembranes,Ο), as ind
was calculated by ﬁtting a sigmoid dose–response function to the data, which was 5.2±1.1 μMdensity gradient followed by equilibrium centrifugation in a swing-
out rotor. Indeed, we have demonstrated the separation of the
membranes into several membrane fractions, including low density
membrane (LDM)- and high density membrane (HDM) fractions. As
shown in Fig. 4B, upper panel, Western blot experiments have
revealed the occurrence of Na,K-ATPase in both the LDM and the HDM
fractions. Subsequently, bothmembrane types were tested in terms of
their susceptibility to curcumin. Curcumin inhibition curves, a
representative of which is shown in Fig. 4B, lower panel, conﬁrmed
the odd drug potency found above with the reconstituted system:
curcumin inhibited Na,K-ATPase in the light fraction with a much
lower potency. Thus, EC50 values for curcumin inhibition were
calculated to 8.1±0.46 μM and 15.8±0.96 μM for the heavy and
light fractions, respectively. There is no evidence for the existence of
different Na,K-ATPase isoforms in renal medulla membranes. Results
in Fig. 4C demonstrate that Na,K-ATPase in both the light and heavy
membrane fractions are inhibited similarly with the water soluble
inhibitor ouabain.
The function of membrane proteins strongly depends on mem-
brane ﬂuidity [35], which is in turn a function of temperature. Hence,
we also looked at the effect of temperature on curcumin potency. As
demonstrated in Fig. 5, the potency of curcumin is signiﬁcantly
modulated by temperature: the EC50 values for curcumin inhibition of
native pig kidney membranes were 19.58±0.28, 11.69±0.16, and
3.8±0.11 at 37 °C, 30 °C, and 20 °C, respectively.
3.4. Curcumin possibly interacts with transmembrane domains of the
pump and is dissociated by detergent
To the best of our knowledge, all known sodium pump inhibitors
tightly bind to the ATPase even after complete solubilization of the
membrane with detergent (however it is expected that a given
detergent may only mildly affect the potency of an inhibitor, see Ref.
[36], but full abrogation of the inhibitor effect following detergent
solubilization is never expected). We have investigated the effect ofof inside-out pumpswasmeasured at 24 °C following pre incubation in 1 mMouabain and
the ouabain concentration in the ATPase reaction was kept constant at 1 mM ouabain to
exception that sphingomylein and cerebrosideswere included togetherwith PC–Chol (raft
ne, pH 7.0, 130 mMNa+, 20 mM K+, 2 mMMgCl2, 20 μMATP (containing 104 cpm AT32P-
nse functionwhich gave an EC50 for inhibition of 9.7±0.34 μMand 25.9±0.52 μM for the
t demonstrates the presence of raft-like domains in native pig renal medulla membranes
the effect of curcumin on pig renal membranes fractions 2 (LDM, □) and 8 (HDM, Ο), as
ed and that the reaction contained 3 mMMgCl2 as well as 3 mM ATP. Data were analyzed
.96 μM for fractions 2 and 8, respectively. C. Shown is the effect of ouabain on pig renal
icated. The ATPasemixturewas identical to that in panel B. The EC50 for ouabain inhibition
and 5.5±0.9 μM for the LDM and HDM, respectively.
Fig. 5. The effect of temperature on curcumin inhibition. In these experiments puriﬁed
membrane-bond Na,K-ATPase was used. The ATPase assays contained 20 mM histidine
buffer, pH 7.0, 130 mMNaCl, 20 mMKCl, 3 mM ATP, 3 mMMgCl2, 3 μg pig kidney Na,K-
ATPase, and the indicated curcumin concentrations. The reactions were performed at
20 °C, 30 °C, or 37 °C, as indicated. Data were analyzed using sigmoid dose–response
function, giving the EC50 values for curcumin inhibition of native pig kidneymembranes
of 19.58±0.28 μM, 11.69±0.16 μM, and 3.8±0.11 μM at 37 °C, 30 °C, and 20 °C,
respectively.
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unanticipated to establish that addition of detergent robustly
decreases the inhibitory potency of curcumin. As demonstrated in
Fig. 6, addition of increasing detergent concentrations to ATPase
mixtures containing 50 μM curcumin resulted in concomitant in-
crease in ouabain-dependent ATP hydrolysis, most likely because of
the dissociation of bound curcumin. At 2 mM detergent the inhibitory
effect of curcumin is fully abolished.
In an attempt to unravel the effect of curcumin on the
conformation of the Na,K-ATPase α-subunit, proteolytic cleavage
have been used. We have previously shown that curcumin destabi-
lizes the conformation of the 19 kDa C-terminal domain of the α-
subunit owing to decreased K+ binding [16]. In the course of our
experiments in this direction we could repeatedly demonstrate thatFig. 6. Effect of C12E10 on curcumin inhibition of Na,K-ATPase. 50 μMcurcumin was used
to inhibit pig kidney Na,K-ATPase and aliquots of the inhibited enzyme was transferred
to ATPase assays containing 50 μM curcumin, 20 mM histidine, pH 7.0, 130 mM Na+,
20 mM K+, 3 mMMgCl2, 3 mMATP, and the indicated C12E10 concentrations. Diamonds
indicate the ATPase activity in the absence of curcumin and either in the absence or in
the presence of 2 mM C12E10. Inset. Curcumin inhibition curves were measured in the
presence of different C12E10 concentrations and the EC50 for curcumin was blotted
against the corresponding C12E10 concentration. At C12E10 concentrationsN2 mM is was
not possible to precisely calculate EC50. Data are expressed as percentage of control,
measured in the absence of curcumin.incubation of Na,K-ATPase lacking its cytoplasmic domains with
curcumin induces cross-linking of several transmembrane domains of
the ATPase (Fig. 7). For comparison, cross-linking with the water
soluble BS3 is shown, which is believed to take place between stalk
segments M5 and M7 (unpublished data). The cross-linking frag-
ments induced in the presence of curcumin are stable in SDS gels
(although the cross-linking efﬁcacy was only 20%, as indicated from
intensity measurement of the 19 kDa and the higher molecular mass
cross-linked fragments), indicating the tight association facilitated by
this polyphenol (see Discussion section).
4. Discussion
4.1. Curcumin does not seem to bind at the extracellular side of the Na,K-
ATPase
Ouabain has been shown to inhibit the ATPase by binding to a
cavity between transmembrane helices M1, M2, M4, M5, and M6 near
the K+-binding sites. In this position the drug is well inserted between
transmembrane domains of the catalytic subunit [37] with no
apparent interaction with the lipid bilayer. We have found that
treatment with curcumin did not modify the apparent afﬁnity for
ouabain (Fig. 1B). As ouabain binds strongly to (i.e., inhibits) the
detergent solubilized ATPase whereas curcumin does not (see later
discussion), it is likely that the interaction site of curcumin is located
at the protein-lipid interface rather than at the extracellular side or
between transmembrane helices. This is in consistence with our
paired inhibitor studies showing that ouabain and curcumin bind to
the ATPase at different sites. Furthermore, the inhibition by
oligomycin is strongly diminished by curcumin treatment, suggesting
that both inhibitors share a common binding site on the protein.
Indeed, previous studies have indicated that oligomycin binds and
dissociates from within the membrane phase [38] consistent with its
interaction with transmembrane domains of the pump. This is in line
with our results in which curcumin is suggested to interact with
transmembrane domain(s) of the α-subunit and explains the
observation that addition of curcumin strongly decreases the
inhibition produced by oligomycin (Fig. 1). It is noteworthy to
mention that both oligomycin and curcumin produce similar
modiﬁcations to the kinetic properties of the Na,K-ATPase [16], withFig. 7. Cross-linking of transmembrane domains of the pump. Incubation with
curcumin or BS3, SDS-PAGE, and immunoblotting was performed as described in
Methods section. In the absence of cross-linking agents the C-terminal fragment is
stained with α-antibody (left panel, left lane) migrates at about 19 kDa on the PVDF
membrane. Cross links appear following treatment with curcumin (right lane) or BS3
(right panel). All stained fragments stained with the α-antibody involve cross-linking
of the 19 kDa fragment to itself or to other transmembrane hairpins.
472 Y.A. Mahmmoud / Biochimica et Biophysica Acta 1808 (2011) 466–473curcumin being less effective as a stabilizer of the E1P conformation
(and hence inhibitor of the reaction cycle) of the Na,K-ATPase.
4.2. Membrane lipids modulate curcumin potency
The increased afﬁnity of inhibition by curcumin of reconstituted
Na,K-ATPase suggests that interaction of the drug with the ATPase is
facilitated by the PC–Chol membranes more than the native renal
medulla embranes. Thus, a change in the membrane structure (and
hence, physical properties) is important in determining the potency of
the drug (see later discussion). In addition, a negatively charged
membrane phospholipid increases the effectiveness of the drug
(Fig. 3). Since PS is believed not to modify membrane ﬂuidity, the
enhancement of curcumin inhibitionmediated by this phospholipid is
most likely a consequence of an increased membrane surface charge
[39] which may facilitate curcumin interaction with the ATPase. PS
has previously been found to modulate the interaction of the Na,K-
ATPase with one of its regulatory proteins [40]. Insertion of curcumin
to a model membrane has been shown to decrease membrane ﬂuidity
and thickness [41,42]. These signiﬁcant effects on the membrane's
physical properties might be indicative of indirect effect on the Na,K-
ATPase through a membrane-mediated mechanism.
Components known to sequester in liquid-ordered phases de-
crease the potency of curcumin inhibition of Na,K-ATPase (Fig. 4).
Rafts are highly ordered membrane domains that contain sphingoli-
pid and cholesterol in tightly packed states. In these domains lipid–
lipid interactions are much more stable relative to lipid–detergent
interactions and hence the membranes are insoluble in Triton X-100
under conditions of low temperatures [43]. It is therefore expected
that curcumin insertion into these domains is rate limiting, so as its
interaction with proteins in these domains (Fig. 4). Indeed, we have
previously determined that the EC50 for curcumin inhibition of shark
Na,K-ATPase is 15.8±1.12 μMagainst 5.24±1.0 μM for the pig kidney
enzyme [16]. Shark enzyme is known to contain much more
cholesterol than the pig kidney membranes [44], demonstrating
that the potency of the drug is a function of the membrane structure.
The inhibition by curcumin was found to increase with decreasing
temperature (Fig. 5). The ﬂuidity of biologicalmembranes is described
by the rate of movement of lipid and protein molecules within the
membranes. Increased lipid packing and decrease in membrane
ﬂuidity is thus consistent with enhanced interaction of the drug with
the pump and can be explained in terms of a decreased rate of
dissociation of the drug from its binding site on the ATPase.
4.3. Interaction of curcumin possibly occurs at the protein-lipid interface
As the inhibitory effect of curcumin is fully abolished following
solubilisation with detergent, it is likely that curcumin interaction
with the ATPase is supported by non-annulus lipids at the lipid-
protein interface. Another possibility is that curcumin is simply
displaced from its binding site up on detergent treatment. This makes
curcumin the ﬁrst known sodium pump inhibitor that absolutely
requires the membrane for interaction with the pump. We demon-
strated also that curcumin addition to isolated transmembrane
domains of the Na,K-ATPase α-subunit resulted in several cross
links on SDS gels (Fig. 7). The cross links seems to involve interaction
between the C-terminal 19 kDa fragment and other transmembrane
hairpins M1M2, M3M4, and M5M6 [45]. The low cross-linking
efﬁciency observed here (about 20%) may indicate that cross-linking
does not correlate with inhibition of ATPase activity. However, we
cannot rule out the possibility that inhibition of the pump is related to
cross-linking of the pump, since a partial cross-linking efﬁcacy could
be an intrinsic property of the cross-linking reaction in vitro due to
conformational ﬂuctuations of the pump [46]. More reliable biophy-
sical experiments would be necessary to study the interaction of
curcumin with the ATPase in the presence of membranes. While thisreport was in preparation, Bernard et al. published results on the
cross-linking of peptides of the cystic ﬁbrosis transmembrane
conductance regulator [47], indicating that curcumin may act by a
general mechanism on several integral membrane proteins. Further
studies are necessary to uncover the nature and possible importance
of the cross-linking induced by curcumin.5. Conclusion
We present evidence for the lipid dependent interaction of
curcumin with the Na,K-ATPase. The lipid dependence possibly
plays a substantial role in the determination of the potency of this
drug. Since solubilisation with low concentrations of C12E10 produces
active Na,K-ATPase and concurrently abolishes curcumin inhibition,
we conclude that curcumin may interact with the Na,K-ATPase at the
protein-lipid interface, with non-annulus lipid being necessary for
this interaction. Hence, hydrophobic drugs may differentially affect
targets inserted in different lipid domains.Acknowledgements
Supported by the Novo Nordic Foundation (R19-A2145), Lundbeck
Foundation (134/05), and Aarhus University Research Foundation.References
[1] H.P.T. Ammon, M.A. Wahl, Pharmacology of Curcuma longa, Planta Med. 57
(1991) 1–7.
[2] J. Epstein, I.R. Sanderson, T.T. MacDonald, Curcumin as a therapeutic agent: the
evidence from in vitro, animal and human studies, Br. J. Nutr. 103 (2010)
1545–1557.
[3] S.C. Gupta, J.H. Kim, S. Prasad, B.B. Aggarwal, Regulation of survival, proliferation,
invasion, angiogenesis, and metastasis of tumor cells through modulation of
inﬂammatory pathways by nutraceuticals, Cancer Metastasis Rev. 29 (2010)
405–434.
[4] M. Nagabhushan, S.V. Bhide, Curcumin as an inhibitor of cancer, J. Am. Coll. Nutr.
11 (1992) 192–198.
[5] M.E. Egan, M. Pearson, S.A. Weiner, V. Rajendran, D. Rubin, J. Glockner-Pagel, S.
Canny, K. Du, G.L. Lukacs, M.J. Caplan, Curcumin, a major constituent of turmeric,
corrects cystic ﬁbrosis defects, Science 304 (2004) 600–602.
[6] F. Yang, G.P. Lim, A.N. Begum, O.J. Ubeda, M.R. Simmons, S.S. Ambegaokar, P.P.
Chen, C.G. Glabe, S.A. Frautschy, G.M. Cole, Curcumin inhibits formation of
amyloid beta oligomers and ﬁbrils, binds plaques, and reduces amyloid in vivo, J.
Biol. Chem. 280 (2005) 5892–5901.
[7] R.C. Reddy, P.G. Vatsala, V.G. Keshamouni, G. Padmanaban, P.N. Rangarajan,
Curcumin for malaria therapy, Biochem. Biophys. Res. Commun. 326 (2005)
472–474.
[8] M. Hasmeda, G.M. Polya, Inhibition of cyclic AMP-dependent protein kinase by
curcumin, Phytochemistry 42 (1996) 599–605.
[9] J.Y. Liu, S.J. Lin, J.K. Lin, Inhibitory effects of curcumin on protein kinase C activity
induced by 12-O-tetradecanoyl-phorbol-13-acetate in NIH 3T3 cells, Carcinogen-
esis 14 (1993) 857–861.
[10] Y.A. Mahmmoud, Modulation of protein kinase C by curcumin; inhibition and
activation switched by calcium ions, Br. J. Pharmacol. 150 (2007) 200–208.
[11] J. Zheng, V.D. Ramirez, Inhibition of mitochondrial proton F0F1-ATPase/ATP
synthase by polyphenolic phytochemicals, Br. J. Pharmacol. 130 (2000)
1115–1123.
[12] S. Singh, B.B. Aggarwal, Activation of transcription factor NF-B is suppressed by
curcumin (Diferuloylmethane), J. Biol. Chem. 270 (1995) 24995–25000.
[13] J.G. Bilmen, S.Z. Khan, M. Javed, F. Michelangeli, Inhibition of the SERCA Ca2+
pumps by curcumin. Curcumin putatively stabilizes the interaction between the
nucleotide-binding and phosphorylation domains in the absence of ATP, Eur. J.
Biochem. 268 (2001) 6318–6327.
[14] M.L. Logan-Smith, P.J. Lockyer, J.M. East, A.G. Lee, Curcumin, a molecule that
inhibits the Ca2+-ATPase of sarcoplasmic reticulum but increases the rate of
accumulation of Ca2+, J. Biol. Chem. 276 (2001) 46905–46911.
[15] C. Sumbilla, D. Lewis, T. Hammerschmidt, G. Inesi, The slippage of the Ca2+ pump
and its control by anions and curcumin in skeletal and cardiac sarcoplasmic
reticulum, J. Biol. Chem. 277 (2002) 13900–13906.
[16] Y.A. Mahmmoud, Curcumin modulation of Na, K-ATPase: phosphoenzyme
accumulation, decreased K+ occlusion, and inhibition of hydrolytic activity, Br.
J. Pharmacol. 145 (2005) 236–245.
[17] Y. Song, N.D. Sonawane, D. Salinas, L. Qian, N. Pedemonte, L.J. Galietta, A.S.
Verkman, Evidence against the rescue of defective DeltaF508-CFTR cellular
processing by curcumin in cell culture and mouse models, J. Biol. Chem. 279
(2004) 40629–40633.
473Y.A. Mahmmoud / Biochimica et Biophysica Acta 1808 (2011) 466–473[18] A. Dragomir, J. Bjorstad, L. Hjelte, G.M. Roomans, Curcumin does not stimulate
cAMP-mediated chloride transport in cystic ﬁbrosis airway epithelial cells,
Biochem. Biophys. Res. Commun. 322 (2004) 447–451.
[19] T.W. Loo, M.C. Bartlett, D.M. Clarke, Thapsigargin or curcumin does not promote
maturation of processing mutants of the ABC transporters, CFTR, and P-
glycoprotein, Biochem. Biophys. Res. Commun. 325 (2004) 580–585.
[20] A.L. Berger, C.O. Randak, L.S. Ostedgaard, P.H. Karp, D.W. Vermeer, M.J. Welsh,
Curcumin stimulates cystic ﬁbrosis transmembrane conductance regulator Cl−
channel activity, J. Biol. Chem. 280 (2005) 5221–5226.
[21] M. Edidin, Lipids on the frontier: a century of cell-membrane bilayers, Nat. Rev.
Mol. Cell Biol. 4 (2003) 414–418.
[22] D. Lingwood, K. Simons, Lipid rafts as a membrane-organizing principle, Science
327 (2010) 46–50.
[23] F.D. Oakley, R.L. Smith, J.F. Engenhardt, Lipid rafts and caveolin-1 coordinate
interleukin-1β (IL-1β)-dependent activation of NFκB by controlling endocytosis
of Nox2 and IL-1β receptor 1 from the plasma membrane, J. Biol. Chem. 284
(2009) 33255–33264.
[24] I. Klodos, M. Esmann, R.L. Post, Large-scale preparation of sodium-potassium
ATPase from kidney outer medulla, Kidney Int. 62 (2002) 2097–2100.
[25] S.J. Karlish, U. Pick, Sidedness of the effects of sodium and potassium ions on the
conformational state of the sodium-potassium pump, J. Physiol. 312 (1981)
505–529.
[26] H.S. Penefsky, A centrifuged-columen procedure for the measurement of ligand
binding by beef heart F1, Meth. Enzymol. 56 (1979) 527–530.
[27] F. Cornelius, Incorporation of C12E10-solubilized Na+, K+-ATPase into liposomes:
determination of sidedness and orientation, Meth. Enzymol. 156 (1988) 156–167.
[28] R. Schroeder, E. London, D. Brown, Interactions between saturated acyl chains
confer detergent resistance on lipids and glycosylphosphatidylinositol (GPI)-
anchored proteins: GPI-anchored proteins in liposomes and cells show similar
behavior, Proc. Natl. Acad. Sci. USA 91 (1994) 12130–12134.
[29] S.J. Karlish, R. Goldshleger, W.D. Stein, A 19-kDa C-terminal tryptic fragment of
the alpha chain of Na/K-ATPase is essential for occlusion and transport of cations,
Proc. Natl. Acad. Sci. USA 87 (1990) 4566–4570.
[30] Y.A. Mahmmoud, F. Cornelius, Protein kinase C phosphorylation of puriﬁed Na, K-
ATPase: C-terminal phosphorylation sites at the alpha- and gamma-subunits close
to the inner face of the plasma membrane, Biophys. J. 82 (2002) 1907–1919.
[31] U.K. Laemmli, Cleavage of structural proteins during the assembly of the head of
bacteriophage T4, Nature 227 (1970) 680–685.
[32] Y.A. Mahmmoud, H. Vorum, F. Cornelius, Identiﬁcation of a phospholemman-like
protein from shark rectal glands. Evidence for indirect regulation of Na, K-ATPase
by protein kinase c via a novel member of the FXYDY family, J. Biol. Chem. 275
(2000) 35969–35977.[33] Y.A. Mahmmoud, G. Cramb, A.B. Maunsbach, C.P. Cutler, L. Meischke, F. Cornelius,
Regulation of Na, K-ATPase by PLMS, the phospholemman-like protein from
shark: molecular cloning, sequence, expression, cellular distribution, and
functional effects of PLMS, J. Biol. Chem. 278 (2003) 37427–37438.
[34] K.S. Song, S. Li, T. Okamoto, L.A. Quilliam, M. Sargiacomo, M.P. Lisanti, Co-
puriﬁcation and direct interaction of Ras with caveolin, an integral membrane
protein of caveolae microdomains, J. Biol. Chem. 271 (1996) 9690–9697.
[35] A.G. Lee, How lipids affect the activities of integral membrane proteins, Biochim.
Biophys. Acta 1666 (2004) 62–87.
[36] A. Gebri, J.M. Maixent, Fatty acid-induced modulation of ouabain responsiveness
of rat Na, K-ATPase isoforms, J. Membr. Biol. 168 (1999) 19–27.
[37] H. Ogawa, T. Shinoda, F. Cornelius, C. Toyoshima, Crystal structure of the sodium
potassium pump (Na+, K+-ATPase) with bound potassium and ouabain, Proc.
Natl. Acad. Sci. USA 106 (2009) 13742–13747.
[38] M. Esmann, Oligomycin interaction with Na, K-ATPase: oligomycin binding and
dissociation are slow processes, Biochim. Biophys. Acta 1064 (1991) 31–36.
[39] T. Yeung, G.E. Gilbert, J. Shi, J. Silvius, A. Kapus, S. Grinstein, Membrane
phosphatidylserine regulates surface charge and protein localization, Science
319 (2008) 210–213.
[40] F. Cornelius Test, Modulation of FXYD interaction with Na,K-ATPase by anionic
phospholipids and protein kinase phosphorylation, Biochemistry 46 (2007)
2371–2379.
[41] W.C. Hung, F.Y. Chen, C.C. Lee, Y. Sun, M.T. Lee, H.W. Huang, Membrane-thinning
effect of curcumin, Biophys. J. 94 (2008) 4331–4338.
[42] H.I. Ingolfsson, R.E. Koeppe, O.S. Andersen, Curcumin is a modulator of bilayer
material properties, Biochemistry 46 (2007) 10384–10391.
[43] D.A. Brown, E. London, Structure and function of sphingolipid- and cholesterol-
rich membrane rafts, J. Biol. Chem. 275 (2000) 17221–17224.
[44] F. Cornelius, N. Turner, H.R. Christensen, Modulation of Na, K-ATPase by
phospholipids and cholesterol. II. Steady-state and presteady-state kinetics,
Biochemistry 42 (2003) 8541–8549.
[45] A. Shainskaya, S.J. Karlish, Evidence that the cation occlusion domain of Na/K-
ATPase consists of a complex of membrane-spanning segments. Analysis of limit
membrane-embedded tryptic fragments, J. Biol. Chem. 269 (1994) 10780–10789.
[46] Y.A. Mahmmoud, H. Vorum, F. Cornelius, Interaction of FXYD10 (PLMS) with Na,
K-ATPase from shark rectal glands. Close proximity of Cys74 of FXYD10 to Cys254
in the A domain of the alpha-subunit revealed by intermolecular thiol cross-
linking, J. Biol. Chem. 280 (2005) 27776–27782.
[47] K. Bernard, W. Wang, R. Narlawar, B. Schmidt, K.L. Kirk, Curcumin cross-links
cystic ﬁbrosis transmembrane conductance regulator (CFTR) polypeptides and
potentiates CFTR channel activity by distinct mechanisms, J. Biol. Chem. 284
(2009) 30754–30765.
